Short-term effects of budesonide, nedocromil sodium and salmeterol on bronchial hyperresponsiveness in childhood asthma

Pediatrics International

Volumn 40, Issue 3, 1998, Pages 247-251

  Baki, Ali ^a   KaragÜZel, GÜLay ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Asthma; Budesonide; Nedocromil sodium; Salmeterol

Indexed keywords

BUDESONIDE; METHACHOLINE; NEDOCROMIL SODIUM; PLACEBO; SALMETEROL;

ADOLESCENT; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ADOLESCENT; ALBUTEROL; ANALYSIS OF VARIANCE; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BUDESONIDE; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MATCHED-PAIR ANALYSIS; NEDOCROMIL; STATISTICS, NONPARAMETRIC;

EID: 0031814459     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1998.tb01921.x     Document Type: Article

References (24)

1. Bewtra Ak, Townley Rg. Bronchial hyperresponsiveness in normal and asthmatic children. In: Tinkelman Dg, Naspitz Ck (eds). Childhood Asthma, Pathophysiology and Treatment. Marcel Dekker Inc. New York, 1993; 29–40.
2. Hargreave Fe. Ryan G., Thompson Nc, O'Byrne Pm, Latimer K., Juniper Ef. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J. Allergy Clin. Immunol. 1981; 68: 347–55.
3. Bel Eh, Timmers Mc, Hermans Jo, Dijkman Jh, Sterk Pj. The long-term effects of nedocromil sodium and beclometha-sone dipropionate on bronchial responsiveness to methacholine in nonatopic asthmatic subjects. Am. Rev. Respir. Dis. 1990; 141: 21–8.
4. Svendsen Ug, Frolund L., Madsen F., Nielsen Nh. A comparison of the effects of nedocromil sodium and beclomethasone dipropionate on pulmonary function, symptoms, and bronchial responsiveness in patients with asthma. J. Allergy Clin. Immunol. 1989:84: 224–31.
5. Foo Al, Lanteri Cj, Burton Pr, Sly Pd. The effect of nedocromil sodium on histamine responsiveness in clinically stable asthmatic children. J. Asthma 1993; 30: 381–90.
6. Verberne Aaph, Hop Wcs, Creyghton Fbm et al. Airway responsiveness after a single dose of salmeterol, and during four months of treatment in children with asthma. Allergy Clin. Immunol. 1996; 97: 938–46.
7. Twentyman Op, Finnerty Jp, Harris A., Palmer J., Holgate St. Protection against allergen-induced asthma by salmeterol. Lancet 1990; 336: 1338–42.
8. Dahl R., Pederson B., Venge P. The influence of inhaled salmeterol on bronchial inflammation: a bronchoalveolar lavage study in patients with bronchial asthma. Am. Rev. Respir. Dis. 1991; 143 (Suppl.): A649.
9. Godfrey Sg. Childhood asthma. In: Clark Tjh, Godfrey Sg, Lee Th (eds). Asthma. Chapman and Hall Medical, London, 1992; 551–605.
10. Eriksson Ne, Whil Ja, Arrendal H., Standhede So. Tree pollen allergy. II. Sensitisation to various tree pollen allergens in Sweden. A multicentre study. Allergy 1984; 39: 610.
11. Chai H., Farr Rs, Froehlich La et al. Standardisation of bronchial inhalation challenge procedures. J. Allergy Clin. Immunol. 1975; 56: 323–7.
12. Kerrebijn Kf, Van Essen-Zandvliet Ee, Neijens Hs. Effect of long-term treatment with glucocorticosteroids and beta agonists on bronchial responsiveness in asthmatic children. J. Allergy Clin. Immunol. 1987; 79: 653–9.
13. Van Essen-Zandvliet Ee, Hughes Md, Waalkens Hj et al. Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. Am. Rev. Respir. Dis. 1992; 146: 547–54.
14. Springer C., Avital A., Maayan Ch, Rosier A., Godfrey S. Comparison of budesonide and beclomethasone dipropionate for treatment of asthma. Arch. Dis Child. 1987; 62: 815–19.
15. Baran D. A comparison of inhaled budesonide and beclomethasone dipropionate in childhood asthma. Br. J. Dis. Chest 1987; 81: 170–5.
16. Henriksen Jm. Effect of inhalation of corticosteroids on exercise-induced asthma: randomised double-blind crossover study of budesonide in asthmatic children. Br. Med. J. 1985; 29: 248–9.
17. Konig P., Hordvik Nl, Kreutz C. The preventive effect and duration of action of NS and cromolyn sodium on exercise-induced asthma in adults. J. Allergy Clin. Immunol. 1987; 79: 64–8.
18. Nair N., Hopp Rs, Townley R. Effect of nedocromil on antigen-induced bronchoconstriction in asthmatic subjects. Ann. Allergy 1989; 62: 329–31.
19. Wonne R., Monkhoff M., Ahrens P., Hoffman D. Study of the protective action of nedocromil sodium with bronchial cold-air provocation in children with bronchial asthma. Pneumologie 1990; 44: 1193–5.
20. Sears Mr, Taylor Dr Print Cg et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336: 1391–6.
21. LÖTvall J., Lunde H., Ullman A., TÖRnqvist H., Svedmyr N. Twelve months treatment with inhaled salmeterol in asthmatic patients. Effects on P2-receptor function and inflammatory cells. Allergy 1992; 47: 477–83.
22. Cheung D., Timmers Mc, Zvinderman Ah, Bel Eh, Dijkman Jh, Sterk Pj. Long-term effects of a long-acting β2- adrenoceptor agonists, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N. Engl. J. Med. 1992; 327: 1198–203.
23. Palmer Jbd, Stuart Am, Shepherd Gl, Viskum K., On behalf of an international study group. Inhaled salmeterol in the treatment of patient with moderate to severe reversible obstructive airways disease: a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 μg) with salmeterol (50 μg). Respir. Med. 1992; 86: 409–17.
24. Gardiner Pv, Ward C., Booth H., Allison A., Hendrick Dj, Walter Eh. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am. J. Respir Crit. Care Med. 1994; 150: 1006–11.